Last €0.48 EUR
Change Today +0.004 / 0.84%
Volume 46.0K
ECR On Other Exchanges
As of 11:38 AM 10/23/14 All times are local (Market data is delayed by at least 15 minutes).

ercros sa (ECR) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/24/13 - €0.62
52 Week Low
07/10/14 - €0.41
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ERCROS SA (ECR)

Related News

No related news articles were found.

ercros sa (ECR) Related Businessweek News

No Related Businessweek News Found

ercros sa (ECR) Details

Ercros, S.A. manufactures and markets basic and intermediate chemicals, plastics, and pharmaceuticals worldwide. Its Basic Chemicals division offers caustic potash and soda, chlorine, chloroisocyanurates, hydrochloric acid, and phosphates, as well as sodium chlorate, chloride, chlorite, and hypochlorite. The company’s products are used in pharmaceuticals, chemical industry, derivatives manufacturing, swimming pools, chemical industry, compound fodder, paper pulp bleaching, textile bleaching, and water treatment applications. Its Plastics division provides EDC, VCM, and PVC products for use in VCM and PVC manufacturing and construction applications. The company’s Intermediate Chemicals division offers formaldehyde, glues and resins, moulding compounds, paraformaldehyde, pentaerythritol, and sodium formate, which are used in derivatives manufacturing, wood industry, electrotechnics, resins, paints, and tanning industry applications. Its Pharmaceuticals division provides erythromycins, fusidic acid, fosfomycins, and statins for use in antibiotic, eye infection, antibiotic, and antihypercholesterol product applications. The company was founded in 1817 and is headquartered in Barcelona, Spain.

Founded in 1817

ercros sa (ECR) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

ercros sa (ECR) Key Developments

Ercros Reports Earnings Results for the Second Quarter and First Half Ended June 30, 2014

Ercros reported earnings results for the second quarter and first half ended June 30, 2014. For the quarter, the company reported sale of goods of EUR 162.21 million against EUR 149.69 million for the first quarter of 2014. Income was EUR 166.01 million, EBITDA was EUR 10.98 million EBIT was EUR 6.29 million, profit from continued operations was EUR 4.22 million, profit before tax was EUR 5.13 million and profit was EUR 5.14 million for the second quarter of 2014. For the first half year, the company reported sale of goods of EUR 311.90 million against EUR 328.92 million for the same period in the last year. This decrease of 5.2% can be explained by the fall in the price of some end products, mainly caustic soda, but also the elimination of unprofitable productions under the 2013 restructuring plan. Income was EUR 313.53 million against EUR 331.98 million for the same period in the last year. EBITDA was EUR 15.40 million against EUR 12.28 million for the same period in the last year. EBIT was EUR 6.06 million against EUR 2.14 million for the same period in the last year. Profit from continued operations was EUR 1.54 million against loss from continued operations of EUR 3.09 million for the same period in the last year. Profit before tax was EUR 2.35 million against loss before tax of EUR 3.72 million for the same period in the last year. Profit was EUR 2.36 million against loss of EUR 3.70 million for the same period in the last year. Net financial debt was EUR 127.80 million as at June 30, 2014 against EUR 133.65 million as at December 31, 2013.

Ercros, S.A. Proposes Amendments to Articles of Association

Ercros, S.A. announced that at its AGM will be held on June 26, 2014, proposed amendments of Articles 25 and 27 of the company's articles of association to adapt them to legislative novelties and introduce improvements to the good governance of the company.

Ercros, S.A., Annual General Meeting, Jun 26, 2014

Ercros, S.A., Annual General Meeting, Jun 26, 2014., at 12:00 Central European Standard Time. Location: Mutua General de Seguros. Agenda: To consider the examination and approval of the individual and consolidated financial statements; to consider the approval of the amendment of articles of association; to consider the re-election of Ernst & Young as the auditor of the company; to consider the authorization in order for the company to acquire treasury shares; to consider the delegation to the board of directors of the power to increase the share capital; to consider the delegation to the board of directors of the power to issue negotiable securities; and to consider the delegation to the board of directors of the powers, in the broadest terms, to interpret, rectify, supplement, execute and carry out the resolutions adopted by the shareholders at the General Meeting, as well as replace any powers that it may receive from the General Meeting and to grant powers to convert these resolutions in public deeds.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ECR:SM €0.48 EUR +0.004

ECR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ECR.
View Industry Companies

Industry Analysis


Industry Average

Valuation ECR Industry Range
Price/Earnings 11.1x
Price/Sales 0.1x
Price/Book 0.3x
Price/Cash Flow 2.4x
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ERCROS SA, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at